• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于心脏组织工程的壳聚糖和明胶水凝胶多层支架,由 PCL 芯支撑。

A multilayered scaffold of a chitosan and gelatin hydrogel supported by a PCL core for cardiac tissue engineering.

机构信息

Department of Bioengineering, Rice University, Houston, TX, USA.

出版信息

Acta Biomater. 2013 Mar;9(3):5630-42. doi: 10.1016/j.actbio.2012.10.032. Epub 2012 Nov 2.

DOI:10.1016/j.actbio.2012.10.032
PMID:23128158
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3562398/
Abstract

A three-dimensional scaffold composed of self-assembled polycaprolactone (PCL) sandwiched in a gelatin-chitosan hydrogel was developed for use as a biodegradable patch with a potential for surgical reconstruction of congenital heart defects. The PCL core provides surgical handling, suturability and high initial tensile strength, while the gelatin-chitosan scaffold allows for cell attachment, with pore size and mechanical properties conducive to cardiomyocyte migration and function. The ultimate tensile stress of the PCL core, made from blends of 10, 46 and 80kDa (Mn) PCL, was controllable in the range of 2-4MPa, with lower average molecular weight PCL blends correlating with lower tensile stress. Blends with lower molecular weight PCL also had faster degradation (controllable from 0% to 7% weight loss in saline over 30 days) and larger pores. PCL scaffolds supporting a gelatin-chitosan emulsion gel showed no significant alteration in tensile stress, strain or tensile modulus. However, the compressive modulus of the composite tissue was similar to that of native tissue (∼15kPa for 50% gelatin and 50% chitosan). Electron microscopy revealed that the gelatin-chitosan gel had a three-dimensional porous structure, with a mean pore diameter of ∼80μm, showed migration of neonatal rat ventricular myocytes (NRVM), maintained NRVM viability for over 7 days, and resulted in spontaneously beating scaffolds. This multi-layered scaffold has sufficient tensile strength and surgical handling for use as a cardiac patch, while allowing migration or pre-loading of cardiac cells in a biomimetic environment to allow for eventual degradation of the patch and incorporation into native tissue.

摘要

一种由自组装聚己内酯(PCL)夹在明胶-壳聚糖水凝胶中的三维支架被开发出来,用作可生物降解的贴片,具有先天性心脏缺陷手术重建的潜力。PCL 核心提供手术处理、可缝合性和初始拉伸强度高,而明胶-壳聚糖支架允许细胞附着,具有有利于心肌细胞迁移和功能的孔径和机械性能。由 10、46 和 80kDa(Mn)PCL 混合制成的 PCL 芯的极限拉伸应力在 2-4MPa 的范围内是可控的,分子量较低的 PCL 混合与较低的拉伸应力相关。分子量较低的 PCL 混合也具有更快的降解(在 30 天内可控制从生理盐水的 0%到 7%的重量损失)和更大的孔。支撑明胶-壳聚糖乳液凝胶的 PCL 支架在拉伸应力、应变或拉伸模量方面没有明显变化。然而,复合组织的压缩模量与天然组织相似(50%明胶和 50%壳聚糖为∼15kPa)。电子显微镜显示,明胶-壳聚糖凝胶具有三维多孔结构,平均孔径约为 80μm,显示出新生大鼠心室肌细胞(NRVM)的迁移,维持 NRVM 活力超过 7 天,并导致自发搏动的支架。这种多层支架具有足够的拉伸强度和手术处理能力,可作为心脏贴片使用,同时允许在仿生环境中迁移或预加载心脏细胞,以实现贴片的最终降解并纳入天然组织。

相似文献

1
A multilayered scaffold of a chitosan and gelatin hydrogel supported by a PCL core for cardiac tissue engineering.用于心脏组织工程的壳聚糖和明胶水凝胶多层支架,由 PCL 芯支撑。
Acta Biomater. 2013 Mar;9(3):5630-42. doi: 10.1016/j.actbio.2012.10.032. Epub 2012 Nov 2.
2
Use of myocardial matrix in a chitosan-based full-thickness heart patch.心肌基质在基于壳聚糖的全层心脏补片中的应用。
Tissue Eng Part A. 2014 Jul;20(13-14):1877-87. doi: 10.1089/ten.TEA.2013.0620. Epub 2014 Feb 24.
3
Multilayered polycaprolactone/gelatin fiber-hydrogel composite for tendon tissue engineering.用于肌腱组织工程的多层聚己内酯/明胶纤维-水凝胶复合材料
Acta Biomater. 2016 Apr 15;35:68-76. doi: 10.1016/j.actbio.2016.03.004. Epub 2016 Mar 2.
4
Polycaprolactone/oligomer compound scaffolds for cardiac tissue engineering.用于心脏组织工程的聚己内酯/低聚物复合支架
J Biomed Mater Res A. 2014 Oct;102(10):3713-25. doi: 10.1002/jbm.a.35045. Epub 2013 Dec 12.
5
Surface modification of nanofibrous polycaprolactone/gelatin composite scaffold by collagen type I grafting for skin tissue engineering.通过I型胶原接枝对纳米纤维聚己内酯/明胶复合支架进行表面改性用于皮肤组织工程
Mater Sci Eng C Mater Biol Appl. 2014 Jan 1;34:402-9. doi: 10.1016/j.msec.2013.09.043. Epub 2013 Oct 5.
6
Evaluation of nanofibrous scaffolds obtained from blends of chitosan, gelatin and polycaprolactone for skin tissue engineering.壳聚糖、明胶和聚己内酯共混物制备的纳米纤维支架在皮肤组织工程中的评价。
Int J Biol Macromol. 2017 Sep;102:1174-1185. doi: 10.1016/j.ijbiomac.2017.05.004. Epub 2017 May 6.
7
Biomimetic fiber/hydrogel composite scaffolds based on chitosan hydrogel and surface modified PCL chopped-microfibers.基于壳聚糖水凝胶和表面改性聚己内酯短切微纤维的仿生纤维/水凝胶复合支架。
Int J Biol Macromol. 2024 Oct;278(Pt 3):134936. doi: 10.1016/j.ijbiomac.2024.134936. Epub 2024 Aug 22.
8
andeffect of polycaprolactone nanofiber coating on polyethylene glycol diacrylate scaffolds for intervertebral disc repair.聚己内酯纳米纤维涂层对用于椎间盘修复的聚乙二醇二丙烯酸酯支架的影响。
Biomed Mater. 2021 May 24;16(4). doi: 10.1088/1748-605X/abfd12.
9
Fabrication and characterization of PCL/gelatin composite nanofibrous scaffold for tissue engineering applications by electrospinning method.静电纺丝法制备和表征用于组织工程应用的 PCL/明胶复合纳米纤维支架。
Mater Sci Eng C Mater Biol Appl. 2013 Apr 1;33(3):1228-35. doi: 10.1016/j.msec.2012.12.015. Epub 2012 Dec 8.
10
Three-dimensional porous biodegradable polymeric scaffolds fabricated with biodegradable hydrogel porogens.采用可生物降解水凝胶致孔剂制备的三维多孔可生物降解聚合物支架。
Tissue Eng Part C Methods. 2009 Dec;15(4):583-94. doi: 10.1089/ten.TEC.2008.0642.

引用本文的文献

1
Application of human cardiac organoids in cardiovascular disease research.人类心脏类器官在心血管疾病研究中的应用。
Front Cell Dev Biol. 2025 Mar 31;13:1564889. doi: 10.3389/fcell.2025.1564889. eCollection 2025.
2
Engineering functional electroconductive hydrogels for targeted therapy in myocardial infarction repair.用于心肌梗死修复靶向治疗的工程化功能性导电水凝胶
Bioact Mater. 2025 Mar 9;49:172-192. doi: 10.1016/j.bioactmat.2025.01.013. eCollection 2025 Jul.
3
Burn wound healing using adipose-derived mesenchymal stem cells and manganese nanoparticles in polycaprolactone/gelatin electrospun nanofibers in rats.

本文引用的文献

1
Cardiac repair achieved by bone marrow mesenchymal stem cells/silk fibroin/hyaluronic acid patches in a rat of myocardial infarction model.骨髓间充质干细胞/丝素蛋白/透明质酸贴片在心肌梗死大鼠模型中的心脏修复作用。
Biomaterials. 2012 Aug;33(22):5541-51. doi: 10.1016/j.biomaterials.2012.04.030. Epub 2012 May 8.
2
Delivery of demineralized bone matrix powder using a thermogelling chitosan carrier.使用热凝胶壳聚糖载体递送脱矿骨基质粉末。
Acta Biomater. 2012 Feb;8(2):753-62. doi: 10.1016/j.actbio.2011.10.030. Epub 2011 Oct 26.
3
Biomaterials advances in patches for congenital heart defect repair.
大鼠中使用脂肪来源间充质干细胞和聚己内酯/明胶电纺纳米纤维中的锰纳米颗粒促进烧伤创面愈合
Bioimpacts. 2024;14(5):30193. doi: 10.34172/bi.2024.30193. Epub 2024 Jan 21.
4
Effects of electrospun fibers containing ascorbic acid on oxidative stress reduction for cardiac tissue engineering.含抗坏血酸的电纺纤维对心脏组织工程中氧化应激降低的影响。
J Appl Polym Sci. 2023 Aug 20;140(32):e54242. doi: 10.1002/app.54242. Epub 2023 May 26.
5
Chondrogenic Potential of Human Adipose-Derived Mesenchymal Stromal Cells in Steam Sterilized Gelatin/Chitosan/Polyvinyl Alcohol Hydrogels.人脂肪间充质基质细胞在蒸汽灭菌明胶/壳聚糖/聚乙烯醇水凝胶中的成软骨潜能
Polymers (Basel). 2023 Sep 29;15(19):3938. doi: 10.3390/polym15193938.
6
Synthesis and Applications of Elastomeric Polymerized High Internal Phase Emulsions (PolyHIPEs).弹性体聚合高内相乳液(聚高内相乳液)的合成与应用
ACS Omega. 2023 May 26;8(23):20178-20195. doi: 10.1021/acsomega.3c01265. eCollection 2023 Jun 13.
7
An immunometabolic patch facilitates mesenchymal stromal/stem cell therapy for myocardial infarction through a macrophage-dependent mechanism.一种免疫代谢贴片通过巨噬细胞依赖性机制促进间充质基质/干细胞治疗心肌梗死。
Bioeng Transl Med. 2022 Dec 13;8(3):e10471. doi: 10.1002/btm2.10471. eCollection 2023 May.
8
Chitosan-Based Scaffolds for the Treatment of Myocardial Infarction: A Systematic Review.壳聚糖基支架治疗心肌梗死的系统评价。
Molecules. 2023 Feb 17;28(4):1920. doi: 10.3390/molecules28041920.
9
Drug-Loaded Biocompatible Chitosan Polymeric Films with Both Stretchability and Controlled Release for Drug Delivery.用于药物递送的具有拉伸性和控释性能的载药生物相容性壳聚糖聚合物薄膜
ACS Omega. 2022 Dec 20;8(1):1282-1290. doi: 10.1021/acsomega.2c06719. eCollection 2023 Jan 10.
10
Artificial Scaffolds in Cardiac Tissue Engineering.心脏组织工程中的人工支架
Life (Basel). 2022 Jul 25;12(8):1117. doi: 10.3390/life12081117.
生物材料在先天性心脏缺陷修复补片中的进展。
J Cardiovasc Transl Res. 2011 Oct;4(5):646-54. doi: 10.1007/s12265-011-9289-8. Epub 2011 Jun 7.
4
Flexural characterization of cell encapsulated PEGDA hydrogels with applications for tissue engineered heart valves.细胞包封的 PEGDA 水凝胶的弯曲特性及其在组织工程心脏瓣膜中的应用。
Acta Biomater. 2011 Jun;7(6):2467-76. doi: 10.1016/j.actbio.2011.02.018. Epub 2011 Feb 15.
5
Heart disease and stroke statistics--2011 update: a report from the American Heart Association.心脏病和中风统计数据--2011 年更新:来自美国心脏协会的报告。
Circulation. 2011 Feb 1;123(4):e18-e209. doi: 10.1161/CIR.0b013e3182009701. Epub 2010 Dec 15.
6
Differential impact of heart rate and blood pressure on outcome in patients with heart failure with reduced versus preserved left ventricular ejection fraction.心率和血压对射血分数降低型与射血分数保留型心力衰竭患者结局的影响差异。
Int J Cardiol. 2012 Mar 8;155(2):249-56. doi: 10.1016/j.ijcard.2010.10.007. Epub 2010 Oct 28.
7
Hydrogels as a platform for stem cell delivery to the heart.水凝胶作为将干细胞输送到心脏的平台。
Congest Heart Fail. 2010 May-Jun;16(3):132-5. doi: 10.1111/j.1751-7133.2010.00145.x.
8
Lyophilized glutaraldehyde-preserved bovine pericardium for experimental atrial septal defect closure.冻干戊二醛保存牛心包用于实验性房间隔缺损闭合。
Eur Cell Mater. 2010 Apr 21;19:158-65. doi: 10.22203/ecm.v019a16.
9
A comparison of mechanical properties of materials used in aortic arch reconstruction.主动脉弓重建中所用材料的力学性能比较。
Ann Thorac Surg. 2009 Nov;88(5):1484-91. doi: 10.1016/j.athoracsur.2009.07.023.
10
Mechanobiology of cardiomyocyte development.心肌细胞发育的力学生物学。
J Biomech. 2010 Jan 5;43(1):93-8. doi: 10.1016/j.jbiomech.2009.09.014. Epub 2009 Oct 12.